Abstract

IntroductionClinical trials and post marketing reports show no safety signals with delayed-release dimethyl fumarate (DMF) exposure during pregnancy; however, these data are limited and the product label recommends use during...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pregnancy Outcomes From an International Registry of Patients Treated With Delayed-release Dimethyl Fumarate
Nicholas J Everage ... Jerome Hanna
Revue Neurologique | VOL. 175
Nicholas J Everage, et. al.Nicholas J Everage ... Jerome Hanna
26 Mar 2019
164 UK/ireland interim results from a DMF pregnancy registry
David Rog ... Nicholas Everage
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 90
David Rog, et. al.David Rog ... Nicholas Everage
14 Nov 2019
Pregnancy outcomes in a dimethyl fumarate exposure registry
Kerstin Hellwig ... Christopher Mcguigan
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 93
Kerstin Hellwig, et. al.Kerstin Hellwig ... Christopher Mcguigan
27 May 2022
Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry.
Kerstin Hellwig ... Oksana Mokliatchouk
Neurology Neuroimmunology & Neuroinflammation | VOL. 9
Kerstin Hellwig, et. al.Kerstin Hellwig ... Oksana Mokliatchouk
23 Nov 2021
View more papers

More From: Journal of Neurology, Neurosurgery & Psychiatry

Paper Title
Journal
Date
Author
088 The clue is in the neck
Jonathan Cleaver ... Elsa Morgan
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 93
Jonathan Cleaver, et. al.Jonathan Cleaver ... Elsa Morgan
27 May 2022
234 Using functional status to aid interpretation of cUHDRS scores in patients with Huntington’s disease
Dylan Trundell ... Jeffery D Long
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 93
Dylan Trundell, et. al.Dylan Trundell ... Jeffery D Long
27 May 2022
015 Reduced risk of secondary progressive multiple sclerosis by treatment with clad- ribine tablets: CLARITY study analysis
Per Soelberg-Sorensen ... Patrick Vermersch
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 93
Per Soelberg-Sorensen, et. al.Per Soelberg-Sorensen ... Patrick Vermersch
27 May 2022
256 FIREFISH part 2: risdiplam efficacy and safety in type 1 SMA
Sabine Fuerst-Recktenwald ... Ksenija Gorni
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 93
Sabine Fuerst-Recktenwald, et. al.Sabine Fuerst-Recktenwald ... Ksenija Gorni
27 May 2022
View more papers